A Valuable COVID Drug Doesn’t Work against New Variants
Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones
Published in Science & Technology
More from Science & TechnologyMore posts in Science & Technology »
- Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles.
- Smell-Loss Tests Could Reveal Health Problems
- Why Primates (Including Humans) Love to Spin Ourselves around until We All Fall Down
- Cases of a Drug-Resistant Fungus Tripled During the COVID Pandemic
- One of the Luckiest Lightning Strikes Ever Recorded
Be First to Comment